Evaluation of a Training Model for the Proficient Use of the Belmont Rapid Infuser
NCT ID: NCT02059109
Last Updated: 2018-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2013-06-30
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypotheses:
1. The use of the traditional method of training is not effective, predicting less then half of staff will pass on the first attempt.
2. Restructured test with hands-on training as opposed to oral presentation only with a written test will result in a pass rate of \> 80%.
3. Staff members who work in pairs will perform better than working alone when setting up the Belmont Rapid Infuser (BRI).
4. Retention at 3 months will be higher with the restructured training method than with the traditional training method.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
NCT01834612
A Device to Determine Return of Sensation From Spinal Block
NCT04553913
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy
NCT00754091
LiDCO Monitor Study
NCT01567371
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
NCT01846195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All participants who pass via either method of training are evaluated again to test retention 3-4 months later .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single
Staff will work alone to assemble the Belmont Rapid Infuser
Hands on Assembly of Belmont Rapid Infuser
Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.
Pair
Staff will work in pairs to assemble the Belmont Rapid Infuser
Hands on Assembly of Belmont Rapid Infuser
Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hands on Assembly of Belmont Rapid Infuser
Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They may have had educational exposure or use of the Belmont Rapid Infuser without independent assembly.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cincinnati Children's Medical Center
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-1844
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.